hydrotropium ethanolamine

Hydrotropium ethanolamine is an investigational drug, likely a derivative or formulation of ethanolamine, being studied for its potential in managing cancer treatment-related hematologic toxicity and as an antineoplastic agent for tumors. Preclinical research on monoethanolamine (Etn), a related compound, suggests it acts by exploiting the selective overexpression of choline kinase in cancer cells. This leads to the accumulation of phosphoethanolamine (PhosE) and the downregulation of Hypoxia-Inducible Factor 1-alpha (HIF-1α), inducing metabolic stress and ultimately cell death in tumor cells. It has been administered in tablet form, indicating an oral route of administration.

Other names

ethanolaminemonoethanolamine